$OPAD
Offerpad Solutions Inc.

2024 Q2 Form 10-Q Financial Statement

#000095017024053581 Filed on May 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $251.1M $285.4M
YoY Change 9.11% -53.19%
Cost Of Revenue $229.3M $262.8M
YoY Change 10.26% -56.37%
Gross Profit $21.87M $22.60M
YoY Change -1.62% 210.16%
Gross Profit Margin 8.71% 7.92%
Selling, General & Admin $30.77M $34.41M
YoY Change -26.31% -39.46%
% of Gross Profit 140.68% 152.28%
Research & Development $964.0K $1.773M
YoY Change -58.3% -20.88%
% of Gross Profit 4.41% 7.85%
Depreciation & Amortization $100.0K $200.0K
YoY Change -50.0% 0.0%
% of Gross Profit 0.46% 0.89%
Operating Expenses $31.73M $36.18M
YoY Change -27.99% -38.75%
Operating Profit -$9.861M -$13.59M
YoY Change -54.84% -73.77%
Interest Expense $4.581M $4.905M
YoY Change 145.37% -34.0%
% of Operating Profit
Other Income/Expense, Net -$3.975M -$3.807M
YoY Change 751.18% -49.5%
Pretax Income -$13.84M -$17.39M
YoY Change -37.96% -70.68%
Income Tax -$54.00K $123.0K
% Of Pretax Income
Net Earnings -$13.78M -$17.52M
YoY Change -38.32% -70.54%
Net Earnings / Revenue -5.49% -6.14%
Basic Earnings Per Share -$0.50 -$0.64
Diluted Earnings Per Share -$0.50 -$0.64
COMMON SHARES
Basic Shares Outstanding 27.30M 27.29M
Diluted Shares Outstanding 27.39M 27.34M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $56.91M $68.55M
YoY Change -50.77% -36.37%
Cash & Equivalents $56.91M $68.55M
Short-Term Investments
Other Short-Term Assets $19.64M $14.34M
YoY Change 27.6% -68.09%
Inventory $307.8M $266.1M
Prepaid Expenses
Receivables $6.745M $4.347M
Other Receivables $0.00 $0.00
Total Short-Term Assets $391.0M $353.3M
YoY Change 13.81% 7.82%
LONG-TERM ASSETS
Property, Plant & Equipment $4.492M $4.679M
YoY Change -7.84% -7.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $11.10M $11.71M
YoY Change 139.06% 126.4%
Total Long-Term Assets $15.59M $16.39M
YoY Change 63.82% 60.05%
TOTAL ASSETS
Total Short-Term Assets $391.0M $353.3M
Total Long-Term Assets $15.59M $16.39M
Total Assets $406.6M $369.7M
YoY Change 15.16% 9.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.838M $4.378M
YoY Change -55.24% -0.93%
Accrued Expenses $13.10M $13.17M
YoY Change -32.05% -36.61%
Deferred Revenue
YoY Change
Short-Term Debt $303.8M $254.6M
YoY Change 58.85% 64.03%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $319.7M $272.1M
YoY Change 47.44% 50.85%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $9.203M $9.349M
YoY Change 261.9% 200.61%
Total Long-Term Liabilities $9.203M $9.349M
YoY Change 261.9% 200.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $319.7M $272.1M
Total Long-Term Liabilities $9.203M $9.349M
Total Liabilities $329.1M $281.6M
YoY Change 49.65% 52.68%
SHAREHOLDERS EQUITY
Retained Earnings -$429.2M -$415.4M
YoY Change 18.41% 22.14%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $77.57M $88.10M
YoY Change
Total Liabilities & Shareholders Equity $406.6M $369.7M
YoY Change 15.16% 9.4%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$13.78M -$17.52M
YoY Change -38.32% -70.54%
Depreciation, Depletion And Amortization $100.0K $200.0K
YoY Change -50.0% 0.0%
Cash From Operating Activities -$54.39M $2.386M
YoY Change -1.02% -99.44%
INVESTING ACTIVITIES
Capital Expenditures $9.000K $353.0K
YoY Change -40.0% 370.67%
Acquisitions
YoY Change
Other Investing Activities $14.00K $30.00K
YoY Change -102.12% -102.48%
Cash From Investing Activities $5.000K -$323.0K
YoY Change -100.74% -74.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 48.85M -3.464M
YoY Change 39.82% -99.18%
NET CHANGE
Cash From Operating Activities -54.39M 2.386M
Cash From Investing Activities 5.000K -323.0K
Cash From Financing Activities 48.85M -3.464M
Net Change In Cash -5.535M -1.401M
YoY Change -73.25% -152.91%
FREE CASH FLOW
Cash From Operating Activities -$54.39M $2.386M
Capital Expenditures $9.000K $353.0K
Free Cash Flow -$54.39M $2.033M
YoY Change -1.04% -99.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001825024
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2024Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.offerpad.com/20240331#AccruedAndOtherCurrentLiabilities
CY2024Q1 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-39641
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
Offerpad Solutions Inc.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-2800538
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2150 E. Germann Road
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Chandler
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85286
CY2024Q1 dei City Area Code
CityAreaCode
844
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
388-4539
CY2024Q1 dei Security12b Title
Security12bTitle
Class A common stock, $0.0001 par value per share
CY2024Q1 dei Trading Symbol
TradingSymbol
OPAD
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27301933
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
68550000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
75967000
CY2024Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
9983000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
3967000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4347000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9935000
CY2024Q1 us-gaap Inventory Net
InventoryNet
266107000
CY2023Q4 us-gaap Inventory Net
InventoryNet
276500000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4353000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5236000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
353340000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
371605000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4679000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4517000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11707000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3572000
CY2024Q1 us-gaap Assets
Assets
369726000
CY2023Q4 us-gaap Assets
Assets
379694000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
4378000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4946000
CY2024Q1 opad Accrued And Other Current Liabilities
AccruedAndOtherCurrentLiabilities
13166000
CY2023Q4 opad Accrued And Other Current Liabilities
AccruedAndOtherCurrentLiabilities
13859000
CY2024Q1 opad Secured Credit Facilities And Notes Payable
SecuredCreditFacilitiesAndNotesPayable
230083000
CY2023Q4 opad Secured Credit Facilities And Notes Payable
SecuredCreditFacilitiesAndNotesPayable
227132000
CY2024Q1 opad Secured Credit Facilities And Notes Payable Net Related Party
SecuredCreditFacilitiesAndNotesPayableNetRelatedParty
24522000
CY2023Q4 opad Secured Credit Facilities And Notes Payable Net Related Party
SecuredCreditFacilitiesAndNotesPayableNetRelatedParty
30092000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
272149000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
276029000
CY2024Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
127000
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
471000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9349000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1418000
CY2024Q1 us-gaap Liabilities
Liabilities
281625000
CY2023Q4 us-gaap Liabilities
Liabilities
277918000
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
503500000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
499660000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-415402000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-397887000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
88101000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
101776000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
369726000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
379694000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
285358000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
609579000
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
262763000
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
602294000
CY2024Q1 us-gaap Gross Profit
GrossProfit
22595000
CY2023Q1 us-gaap Gross Profit
GrossProfit
7285000
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
22452000
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
42351000
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11955000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14479000
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1773000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2241000
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
36180000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
59071000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-13585000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-51786000
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-344000
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
389000
CY2024Q1 us-gaap Interest Expense
InterestExpense
4905000
CY2023Q1 us-gaap Interest Expense
InterestExpense
7432000
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
754000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
282000
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3807000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7539000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17392000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-59325000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
123000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
122000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-17515000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-59447000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.64
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.51
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.64
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.51
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27339000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23661000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27339000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23661000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
101776000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
16000
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-43000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3867000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-17515000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
88101000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
121877000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
49000
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-48000
CY2023Q1 opad Issuanceo F Pre Funded Warrants Net
IssuanceoFPreFundedWarrantsNet
89216000
CY2023Q1 opad Exercise Of Pre Funded Warrants
ExerciseOfPreFundedWarrants
11000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1843000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-59447000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
153501000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-17515000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-59447000
CY2024Q1 us-gaap Depreciation
Depreciation
166000
CY2023Q1 us-gaap Depreciation
Depreciation
202000
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
818000
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
894000
CY2024Q1 us-gaap Inventory Write Down
InventoryWriteDown
624000
CY2023Q1 us-gaap Inventory Write Down
InventoryWriteDown
7285000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3867000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1843000
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-344000
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
389000
CY2024Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
0
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-568000
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
5000
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
CY2024Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-5588000
CY2023Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
54000
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-9769000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-484761000
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-670000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1710000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-568000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-228000
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-684000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-8060000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2386000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
426443000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
353000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
75000
CY2024Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
30000
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
CY2024Q1 us-gaap Payments For Derivative Instrument Investing Activities
PaymentsForDerivativeInstrumentInvestingActivities
0
CY2023Q1 us-gaap Payments For Derivative Instrument Investing Activities
PaymentsForDerivativeInstrumentInvestingActivities
1212000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-323000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1287000
CY2024Q1 opad Borrowings From Credit Facilities And Notes Payable
BorrowingsFromCreditFacilitiesAndNotesPayable
242142000
CY2023Q1 opad Borrowings From Credit Facilities And Notes Payable
BorrowingsFromCreditFacilitiesAndNotesPayable
186391000
CY2024Q1 opad Repayments Of Credit Facilities And Notes Payable
RepaymentsOfCreditFacilitiesAndNotesPayable
245579000
CY2023Q1 opad Repayments Of Credit Facilities And Notes Payable
RepaymentsOfCreditFacilitiesAndNotesPayable
700635000
CY2024Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0
CY2023Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
23000
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
16000
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
49000
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
43000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
48000
CY2024Q1 opad Borrowings From Warehouse Lending Facility
BorrowingsFromWarehouseLendingFacility
0
CY2023Q1 opad Borrowings From Warehouse Lending Facility
BorrowingsFromWarehouseLendingFacility
8188000
CY2024Q1 opad Repayments Of Warehouse Lending Facility
RepaymentsOfWarehouseLendingFacility
0
CY2023Q1 opad Repayments Of Warehouse Lending Facility
RepaymentsOfWarehouseLendingFacility
5657000
CY2024Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0
CY2023Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
90000000
CY2024Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0
CY2023Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
11000
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-784000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3464000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-422508000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1401000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2648000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
79934000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
140299000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
78533000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
142947000
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
68550000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
107733000
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
9983000
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
35214000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
78533000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
142947000
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
6427000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
11064000
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-left:2.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.667%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="margin-left:2.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.667%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of the Company’s condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements. Significant estimates include those related to the net realizable value of real estate inventory, among others. Actual results could differ from those estimates.</span></p>
CY2023Q4 us-gaap Inventory Finished Homes
InventoryFinishedHomes
148648000
CY2024Q1 opad Inventory Homes Under Contract To Sell
InventoryHomesUnderContractToSell
91094000
CY2024Q1 us-gaap Inventory Write Down
InventoryWriteDown
600000
CY2023Q1 us-gaap Inventory Write Down
InventoryWriteDown
7300000
CY2024Q1 us-gaap Inventory Real Estate Construction In Process
InventoryRealEstateConstructionInProcess
67849000
CY2023Q4 us-gaap Inventory Real Estate Construction In Process
InventoryRealEstateConstructionInProcess
53116000
CY2024Q1 us-gaap Inventory Finished Homes
InventoryFinishedHomes
107164000
CY2023Q4 opad Inventory Homes Under Contract To Sell
InventoryHomesUnderContractToSell
74736000
CY2024Q1 us-gaap Inventory Net
InventoryNet
266107000
CY2023Q4 us-gaap Inventory Net
InventoryNet
276500000
CY2023Q1 opad Payment To Acquire Options
PaymentToAcquireOptions
1200000
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-600000
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8041000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7725000
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3362000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3208000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4679000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4517000
CY2024Q1 us-gaap Depreciation
Depreciation
200000
CY2023Q1 us-gaap Depreciation
Depreciation
200000
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
900000
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
600000
CY2024Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
100000
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
100000
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y8M12D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y9M18D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.07
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.043
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1760000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2898000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2089000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1949000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1922000
CY2024Q1 opad Lessee Operating Lease Liability Payment Due Year Six
LesseeOperatingLeaseLiabilityPaymentDueYearSix
11862000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
24454000
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
7388000
CY2024Q1 us-gaap Incentive From Lessor
IncentiveFromLessor
5532000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
11534000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10538000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3338000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2185000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2271000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9349000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1418000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
11534000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3689000
CY2024Q1 opad Accrued Home Renovation Payable Current
AccruedHomeRenovationPayableCurrent
4004000
CY2023Q4 opad Accrued Home Renovation Payable Current
AccruedHomeRenovationPayableCurrent
3534000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2185000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2271000
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2048000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3200000
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
1659000
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1989000
CY2024Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
1018000
CY2023Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
999000
CY2024Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
604000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
392000
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1648000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1474000
CY2024Q1 opad Accrued And Other Current Liabilities
AccruedAndOtherCurrentLiabilities
13166000
CY2023Q4 opad Accrued And Other Current Liabilities
AccruedAndOtherCurrentLiabilities
13859000
CY2024Q1 us-gaap Advertising Expense
AdvertisingExpense
4400000
CY2023Q1 us-gaap Advertising Expense
AdvertisingExpense
8000000
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1408000
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
2226000
CY2024Q1 us-gaap Notes And Loans Payable
NotesAndLoansPayable
254605000
CY2023Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
257224000
CY2024Q1 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
230083000
CY2023Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
227132000
CY2024Q1 opad Notes And Loans Payable Related Parties Current
NotesAndLoansPayableRelatedPartiesCurrent
24522000
CY2023Q4 opad Notes And Loans Payable Related Parties Current
NotesAndLoansPayableRelatedPartiesCurrent
30092000
CY2024Q1 us-gaap Notes And Loans Payable
NotesAndLoansPayable
254605000
CY2023Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
257224000
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q1 opad Warrantsexpirationperiodaftercompletionofbusinesscombinationorearlieruponredemptionorliquidationdate
Warrantsexpirationperiodaftercompletionofbusinesscombinationorearlieruponredemptionorliquidationdate
2026-09-01
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2024Q1 opad Shares Authorized
SharesAuthorized
2100000000
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
100000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
100000
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1000000
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y14D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
400000
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
700000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3867000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1843000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-17515000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-59447000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27339000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23661000
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2024Q1 opad Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock Units
IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStockUnits
0
CY2023Q1 opad Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock Units
IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStockUnits
0
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27339000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23661000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.64
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.51
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.64
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.51
CY2024Q1 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2023Q1 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.007
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.002
CY2024Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
111000000
CY2024Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
352000
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
768000
CY2024Q1 opad Contractual Obligation To Purchase Home
ContractualObligationToPurchaseHome
545
CY2024Q1 us-gaap Contractual Obligation
ContractualObligation
156400000
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-053581-index-headers.html Edgar Link pending
0000950170-24-053581-index.html Edgar Link pending
0000950170-24-053581.txt Edgar Link pending
0000950170-24-053581-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img223553162_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
opad-20240331.htm Edgar Link pending
opad-20240331.xsd Edgar Link pending
opad-ex31_1.htm Edgar Link pending
opad-ex31_2.htm Edgar Link pending
opad-ex32_1.htm Edgar Link pending
opad-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
opad-20240331_htm.xml Edgar Link completed
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending